Arsenic trioxide induces apoptosis in pancreatic cancer cells via changes in cell cycle, caspase activation, and GADD

Xinquan Li1, Xianzhong Ding, Thomas E Adrian

  • 1Department of Surgery, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.

Pancreas
|July 29, 2003
PubMed

Insights

Arsenic trioxide effectively triggers apoptosis in human pancreatic cancer cells by activating caspases and the mitochondrial pathway. This mechanism also involves cell cycle arrest and GADD gene expression, suggesting its potential for pancreatic cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Pancreatic cancer remains a significant health challenge with limited effective treatments.
  • Arsenic trioxide has shown promise in inhibiting cancer cell proliferation and inducing apoptosis.
  • Understanding the precise mechanisms of arsenic trioxide's action in pancreatic cancer is crucial for therapeutic development.

Purpose of the Study:

  • To investigate the molecular mechanisms by which arsenic trioxide induces apoptosis in human pancreatic cancer cells.
  • To elucidate the role of the caspase cascade, mitochondrial pathway, and cell cycle regulation in arsenic trioxide-mediated apoptosis.
  • To explore the potential of arsenic trioxide as a therapeutic agent for pancreatic cancer.

Main Methods:

  • Utilized MiaPaCa2 and PANC-1 human pancreatic cancer cell lines.
  • Assessed apoptosis through caspase activation (caspase-3, -7, -9), poly ADP ribose polymerase (PARP) cleavage, and Bcl-2 family protein expression analysis.
  • Analyzed cell cycle distribution using flow cytometry and examined the expression of cell cycle regulatory proteins (p21, cyclins, CDKs) and GADD genes (GADD45, GADD153).

Main Results:

  • Arsenic trioxide activated caspase-3, -7, and -9, leading to PARP cleavage, indicating caspase cascade activation.
  • Downregulation of anti-apoptotic proteins (Bcl-2, Mcl-1) and upregulation of pro-apoptotic Bax protein were observed.
  • Arsenic trioxide induced cell cycle arrest at G0/G1 and G2/M phases, increased the sub-G0/G1 apoptotic population, and modulated the expression of p21, cyclins, and GADD genes.

Conclusions:

  • Arsenic trioxide induces apoptosis in pancreatic cancer cells via the mitochondrial pathway and caspase activation.
  • The drug modulates cell cycle progression and enhances GADD gene expression.
  • These findings highlight arsenic trioxide's potential as a valuable therapeutic option for pancreatic cancer.

Related Concept Videos

Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...